📣 VC round data is live. Check it out!
- Public Comps
- AmorePacific
AmorePacific Valuation Multiples
Discover AmorePacific's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Fielmann Group, Yakult Honsha, Giant Biogene, GSK India and more.
AmorePacific Overview
About AmorePacific
AmorePacific Corp is a Korea-based company engaged in the manufacture and sale of beauty, personal care, and household products. The company operates through two main divisions: the Cosmetics Business Division, which includes premium and luxury brands such as Sulwhasoo, Hera, Laneige, IOPE, Aestura, and COSRX; and the Daily Beauty (DB) Business Division, which focuses on household and personal care brands including Ryeo, Mise-en-scene, and Happy Bath. It generates the majority of its revenue from the Cosmetics business division.
Founded
2006
HQ

Employees
4.7K
Website
Sectors
Financials (LTM)
EV
$4B
Valuation Multiples
Start free trialAmorePacific Financials
AmorePacific reported last 12-month revenue of $3B and EBITDA of $432M.
In the same LTM period, AmorePacific generated $2B in gross profit, $432M in EBITDA, and $197M in net income.
Revenue (LTM)
AmorePacific P&L
In the most recent fiscal year, AmorePacific reported revenue of $3B and EBITDA of $420M.
AmorePacific is profitable as of last fiscal year, with gross margin of 70%, EBITDA margin of 14%, and net margin of 6%.
Financial data powered by Morningstar, Inc.
AmorePacific Stock Performance
AmorePacific has current market cap of $4B, and enterprise value of $4B.
Market Cap Evolution
AmorePacific's stock price is $64.90.
AmorePacific share price decreased by 5.3% in the last 30 days, and by 21.4% in the last year.
AmorePacific has an EPS (earnings per share) of $2.39.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4B | $4B | -2.1% | -5.3% | -22.3% | -21.4% | $2.39 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAmorePacific Valuation Multiples
AmorePacific trades at 1.3x EV/Revenue multiple, and 9.2x EV/EBITDA.
EV / Revenue (LTM)
AmorePacific Financial Valuation Multiples
As of June 4, 2026, AmorePacific has market cap of $4B and EV of $4B.
AmorePacific has a P/E ratio of 22.7x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified AmorePacific Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


AmorePacific Margins & Growth Rates
AmorePacific grew revenue by 5% and EBITDA by 12% in the last fiscal year.
In the most recent fiscal year, AmorePacific reported gross margin of 70%, EBITDA margin of 14%, and net margin of 6%.
AmorePacific Margins
AmorePacific Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
AmorePacific Operational KPIs
AmorePacific's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.4M for the same period.
AmorePacific's Rule of 40 is 24% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
AmorePacific's Rule of X is 36% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
AmorePacific Competitors
AmorePacific competitors include Fielmann Group, Yakult Honsha, Giant Biogene, GSK India, Proya Cosmetics, Bausch + Lomb, Hengan Group, Unilever Indonesia, Rohto Pharmaceutical and Colgate-Palmolive (India).
Most AmorePacific public comparables operate across Health & Beauty.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.8x | 1.7x | 7.5x | 7.4x | |||
| 1.3x | 1.3x | 6.0x | 8.8x | |||
| 3.3x | 3.2x | 7.5x | 8.0x | |||
| 9.0x | 8.8x | 23.2x | 25.6x | |||
| 2.0x | 2.0x | 10.7x | 10.8x | |||
| 2.0x | 1.9x | 11.4x | 10.7x | |||
| 1.0x | 1.0x | 5.3x | 5.8x | |||
| 1.7x | 1.7x | 11.0x | 10.7x | |||
This data is available for Pro users. Sign up to see all AmorePacific competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by AmorePacific
AmorePacific has acquired 2 companies to date.
Last acquisition by AmorePacific was on October 30th 2023. AmorePacific acquired COSRX for $1B (EV/Revenue multiple available to Pro users).
Latest Acquisitions by AmorePacific
| Description | COSRX is a Seoul-based skincare brand offering K-beauty products through its e-commerce platform and global retailers. The company produces low-irritant formulations featuring snail mucin, centella asiatica, and salicylic acid in serums, masks, and cleansers. Popular lines include Advanced Snail 96 Mucin Power Essence and Acne Pimple Master Patch sold in over 50 countries. COSRX maintains manufacturing in South Korea with dermatologist-tested, pH-balanced products for acne-prone and sensitive skin types. | Tata’s Natural Alchemy is a skincare brand producing organic anti-aging serums, cleansers, moisturizers, and masks from plant-based ingredients. Vermont-based Tata Harper sources farms in the US for products sold online and in luxury retailers worldwide. |
| HQ Country | ||
| HQ City | Seoul | - |
| Deal Date | 30 Oct 2023 | 1 Sep 2022 |
| Valuation | $1B | $124M |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all AmorePacific acquisitions and their M&A valuation multiples. Start Free Trial | ||
Investments by AmorePacific
AmorePacific has invested in 10 companies to date.
Latest investment by AmorePacific was on March 26th 2026. AmorePacific invested in VIOL in their Strategic investment round.
Latest Investments by AmorePacific
| Description | VIOL Co Ltd is engaged in manufacturing and marketing of medical devices for skincare treatment and recovery. The product portfolio includes SkinStamp, SYLFIRM, SCARLET, O Media - RS, O Media - RI, and O Media - Hmgf H. | Refilled is a Seoul-based provider of personalized hair loss treatment services delivered directly to homes. Drawing from clinical research on hair loss patterns, the company customizes care kits with shampoos, serums, and supplements suited to individual scalp conditions. Customers receive ongoing consultations via app to track progress and adjust regimens. Operating in South Korea, Refilled partners with dermatologists to ensure treatments align with medical standards for androgenetic alopecia and other common types. | Tiptoe is a Seoul-based cosmetics manufacturer producing beauty products for women interested in fashion-forward skincare and makeup. Its retail line includes creams, serums, and color cosmetics distributed through Korean department stores and online channels. | Caregen Co Ltd is in the business of research and marketing of Biomimetic peptides and Growth factors. It also offers customized Biomimetic Peptides and toll manufacturing services. The firm's business areas include research and development, production and supply of active ingredients, production and global distribution of Cosmeceuticals and Medical devices and global operation of hair care center. The company's products include CG-Illugen, CG-Nugenerin, CG-Fibrofillin, CG-EGF etc. | |
| HQ Country | |||||
| HQ City | - | Seoul | Seoul | - | |
| Deal Date | 26 Mar 2026 | 2 Mar 2026 | 11 Sep 2025 | 14 Nov 2023 | |
| Round | Strategic investment | Undisclosed stage | Seed | Strategic investment | |
| Raised | undisclosed | $8M | $1M | $8M | |
| Investors | AmorePacific | AmorePacific; D·CAMP; Hana Ventures; Korea Investment Partners; KT Investment; Laguna Investment | AmorePacific; KD&J Partners; Schmidt | AmorePacific | |
| Valuation | undisclosed | undisclosed | $8M | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all AmorePacific investments and their VC round multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout AmorePacific
| When was AmorePacific founded? | AmorePacific was founded in 2006. |
| Where is AmorePacific headquartered? | AmorePacific is headquartered in South Korea. |
| How many employees does AmorePacific have? | As of today, AmorePacific has over 4K employees. |
| Is AmorePacific publicly listed? | Yes, AmorePacific is a public company listed on Korea Exchange. |
| What is the stock symbol of AmorePacific? | AmorePacific trades under 090430 ticker. |
| When did AmorePacific go public? | AmorePacific went public in 2006. |
| Who are competitors of AmorePacific? | AmorePacific main competitors include Fielmann Group, Yakult Honsha, Giant Biogene, GSK India, Proya Cosmetics, Bausch + Lomb, Hengan Group, Unilever Indonesia, Rohto Pharmaceutical, Colgate-Palmolive (India). |
| What is the current market cap of AmorePacific? | AmorePacific's current market cap is $4B. |
| What is the current revenue of AmorePacific? | AmorePacific's last 12 months revenue is $3B. |
| What is the current revenue growth of AmorePacific? | AmorePacific revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of AmorePacific? | Current revenue multiple of AmorePacific is 1.3x. |
| What is the current EBITDA of AmorePacific? | AmorePacific's last 12 months EBITDA is $432M. |
| What is AmorePacific's EBITDA margin? | AmorePacific's last 12 months EBITDA margin is 15%. |
| What is the current EV/EBITDA multiple of AmorePacific? | Current EBITDA multiple of AmorePacific is 9.2x. |
| What is the current FCF of AmorePacific? | AmorePacific's last 12 months FCF is $319M. |
| What is AmorePacific's FCF margin? | AmorePacific's last 12 months FCF margin is 11%. |
| What is the current EV/FCF multiple of AmorePacific? | Current FCF multiple of AmorePacific is 12.5x. |
| How many companies AmorePacific has acquired to date? | As of June 2026, AmorePacific has acquired 2 companies. |
| What was the largest acquisition by AmorePacific? | $1B acquisition of COSRX on 30th October 2023 was the largest M&A AmorePacific has done to date. |
| What companies AmorePacific acquired? | AmorePacific acquired COSRX and Tata’s Natural Alchemy. |
| In how many companies AmorePacific has invested to date? | As of June 2026, AmorePacific has invested in 10 companies. |
| What was the last AmorePacific investment? | On 26th March 2026 AmorePacific invested in VIOL, participating in a Strategic investment round. |
| In what companies AmorePacific invested in? | AmorePacific invested in RXC, DMIL, Caregen Co, Refilled, Onesell, Ice creative, FREECO, Tiptoe, Lazy Society, and VIOL. |
See public comps similar to AmorePacific
Lists including AmorePacific
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

